Cours du GOLF 2007Prise en charge dignostique et thérapeutique du mésothéliome pleural malin en 2007Epidemiology, molecular biology, diagnostic and therapeutic strategy of malignant pleural mesothelioma in 2007 - an update
Références (48)
- et al.
Molecular pathways in malignant pleural mesothelioma
Cancer Lett
(2006) Implications of P16/CDKN2A deletion in pleural mesotheliomas
Lung Cancer
(2005)- et al.
Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma
Biochem Biophys Res Commun
(2006) - et al.
EGFR overexpression in malignant pleural mesothelioma. An immunohistochemical and molecular study with clinico-pathological correlations
Lung Cancer
(2006) - et al.
SYT-SSX fusion is absent in sarcomatoid mesothelioma allowing its distinction from synovial sarcoma of the pleura
Mod Pathol
(2007) - et al.
Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases
Chest
(1996) - et al.
Mesothelin-family proteins and diagnosis of mesothelioma
Lancet
(2003) Positron emission tomography in the diagnosis of mesothelioma
Lung Cancer
(2004)- et al.
Therapy response evaluation in malignant pleural mesothelioma with integrated PET-CT imaging
Lung Cancer
(2005) Guidelines of the French Speaking Society for Chest Medicine for management of malignant pleural mesothelioma
Respir Med
(2007)
Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy
Chest
(1995)
Re: a multicenter phase II study of gemcitabine and oxaliplatin for malignant pleural mesothelioma
Clin Lung Cancer
(2003)
The French National Mesothelioma Surveillance Program
Occup Environ Med
(2006)
Past occupational exposure to asbestos among men in France
Scand J Work Environ Health
(2000)
Can exposure to very low levels of asbestos induce pleural mesothelioma?
Am J Respir Crit Care Med
(2005)
Malignant mesothelioma mortality in the United States, 1999-2001
Int J Occup Environ Health
(2006)
Update on the molecular biology of malignant mesothelioma
Cancer
(2007)
Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study
Mutat Res
(2006)
Angiogenic cytokines in mesothelioma: a study of VEGF, FGF-1 and -2, and TGF beta expression
J Pathol
(1999)
Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey
Cancer Res
(2006)
High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas
Proc Natl Acad Sci USA
(1995)
Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK
Oncogene
(2006)
Alterations of the p16 (INK4) locus in human malignant mesothelial tumors
Carcinogenesis
(2002)
Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma
Cancer Res
(2001)
Cited by (0)
Copyright © 2007 SPLF. Published by Elsevier Masson SAS All rights reserved.